glp 1 induced pancreatitis Updates in Medicine | GLP-1s may raise risk early—but over time, protective effects balance the scale, resulting in no increase in overall 1-year risk Glucagon-like Peptide 1 Receptor Signaling

Description

Ongoing treatment depends on: Continued clinical benefit Safety and tolerability Remaining within eligibility criteria defined by the PGD GLP-1 medicines are not intended to be lifelong by default , and all patients are reviewed regularly

Those are big ranges in protein, fiber & calories..odd they don't list carbs it's also odd (& incorrect) that they have called these Ozempic smoothies since Ozempic is the dose of semaglutide for T2 diabetes & WEGOVY is the dosage for obesity management

Early findings suggest that tirzepatide may calm low-grade inflammation more effectively than semaglutide, supporting better body composition and cardiovascular outcomes